400-808-1701 登录/注册购物车(0)

首页 > SCI期刊 > 医学期刊 > Diabetes & Metabolic Syndrome-clinical Research & Reviews(非官网)

收藏该杂志

同大类学科其它级别期刊：

中科院 1区期刊 JCR Q1 期刊中科院 2区期刊 JCR Q2 期刊中科院 3区期刊 JCR Q3 期刊中科院 4区期刊 JCR Q4 期刊

Diabetes & Metabolic Syndrome-clinical Research & Reviews

SCIE

国际简称：DIABETES METAB SYND 参考译名：糖尿病与代谢综合征-临床研究与评论

主要研究方向：ENDOCRINOLOGY & METABOLISM 非预警期刊

《糖尿病与代谢综合征-临床研究与评论》(Diabetes & Metabolic Syndrome-clinical Research & Reviews)是一本由Elsevier出版的以ENDOCRINOLOGY & METABOLISM为研究特色的国际期刊，发表该领域相关的原创研究文章、评论文章和综述文章，及时报道该领域相关理论、实践和应用学科的最新发现，旨在促进该学科领域科学信息的快速交流。该期刊是一本未开放期刊，近三年没有被列入预警名单。

3区中科院分区
Q2 JCR分区
72 年发文量
4.4 IF影响因子
未开放 是否OA
6 issues/year 出版周期
English 出版语言

Diabetes&Metabolic Syndrome clinical Research&Reviews is an academic journal focusing on clinical research and review in the field of diabetes and metabolic syndrome. It aims to provide a platform for medical researchers, clinicians and public health experts worldwide to exchange and share the latest research results, clinical experience and treatment methods. As an international academic journal, it covers all aspects of diabetes and metabolic syndrome, including etiology, pathophysiology, diagnostic methods, drug treatment, non drug treatment, complication management and preventive measures. It not only focuses on the latest progress in basic research, but also focuses on the application and innovation in clinical practice. In terms of content, he mainly published original research papers, systematic reviews, case reports, clinical trials, meta-analysis, policy forums, educational reviews and other types of articles, covering various fields of diabetes and metabolic syndrome, providing readers with a comprehensive and in-depth understanding.

[ 查看全部 ]

投稿咨询加急咨询

Diabetes & Metabolic Syndrome-clinical Research & Reviews期刊信息

ISSN：1871-4021
出版语言：English
是否OA：未开放
E-ISSN：1878-0334
出版地区：ENGLAND
是否预警：否
出版商：Elsevier
出版周期：6 issues/year
开源占比：0.012
Gold OA文章占比：21.07%
OA被引用占比：0.0018...
出版国人文章占比：0
出版撤稿占比：
研究类文章占比：73.61%

Diabetes & Metabolic Syndrome-clinical Research & Reviews CiteScore评价数据（2026年6月最新版）

CiteScore

SJR

SNIP

CiteScore 指数

8.6

1.17

1.245

学科类别	分区	排名	百分位
大类：Medicine 小类：Internal Medicine	Q1	28 / 179	84%
大类：Medicine 小类：Endocrinology, Diabetes and Metabolism	Q1	39 / 250	84%

名词解释：CiteScore 是衡量期刊所发表文献的平均受引用次数，是在 Scopus 中衡量期刊影响力的另一个指标。当年CiteScore 的计算依据是期刊最近4年（含计算年度）的被引次数除以该期刊近四年发表的文献数。例如，2022年的 CiteScore 计算方法为：2022年的 CiteScore =2019-2022年收到的对2019-2022年发表的文件的引用数量÷2019-2022年发布的文献数量注：文献类型包括：文章、评论、会议论文、书籍章节和数据论文。

Diabetes & Metabolic Syndrome-clinical Research & Reviews中科院评价数据

《新锐期刊分区表》（2026年3月发布）

Top期刊	综述期刊	大类学科		小类学科
否	否	医学	3区	ENDOCRINOLOGY & METABOLISM 内分泌学与代谢	3区

Diabetes & Metabolic Syndrome-clinical Research & Reviews JCR评价数据

2025-2026年最新版

按JCI指标学科分区	收录子集	分区	排名	百分位
学科：ENDOCRINOLOGY & METABOLISM	ESCI	Q2	59 / 198	70.5
学科：ENDOCRINOLOGY & METABOLISM	ESCI	Q2	84 / 198	57.83

Diabetes & Metabolic Syndrome-clinical Research & Reviews历年数据统计

影响因子

中科院分区

Diabetes & Metabolic Syndrome-clinical Research & Reviews中国学者发文选摘

1、Predictive effect of FT3 levels on normal thyroid function in patients with type 2 diabetic kidney disease: A cross-sectional analysis of inpatients in Chin
Author: Zhong, Weili; Yue, Jinfeng; Zhang, Chunhuo; Niu, Shuying; Zhao, Yanli; Zhao, Shangshuang; Yu, Ying; Li, Jing; Han, Jun

Journal: DIABETES & METABOLIC SYNDROME-CLINICAL RESEARCH & REVIEWS. 2026; Vol. 20, Issue 3, pp. -. DOI: 10.1016/j.dsx.2026.103400
2、People living with diabetes with sodium-glucose cotransporter-2 inhibitors use are at an increased risk of future total knee joint replacemen
Author: Hu, Wei-Syun; Lin, Cheng-Li

Journal: DIABETES & METABOLIC SYNDROME-CLINICAL RESEARCH & REVIEWS. 2026; Vol. 20, Issue 3, pp. -. DOI: 10.1016/j.dsx.2026.103402
3、Efficacy and safety of finerenone in the treatment of primary aldosteronism: A prospective clinical stud
Author: Li, Shuo; Zhang, Yifan; Liu, Xuan; Chai, Yun; Jia, Hongwei; Shu, Hua; Fan, Yuxin; Ding, Li; Liu, Ming

Journal: DIABETES & METABOLIC SYNDROME-CLINICAL RESEARCH & REVIEWS. 2026; Vol. 20, Issue 1, pp. -. DOI: 10.1016/j.dsx.2025.103369
4、Prediction of retinopathy risk: A prospective cohort study in Chin
Author: Xu, Xiaohan; Wang, Duolao; Alam, Uazman; Qiu, Shanhu; Ding, Yuzhi; Sun, Zilin; Garrib, Anupam

Journal: DIABETES & METABOLIC SYNDROME-CLINICAL RESEARCH & REVIEWS. 2025; Vol. 19, Issue 5, pp. -. DOI: 10.1016/j.dsx.2025.103251
5、Association between metabolically healthy obesity and atrial fibrillation: A systematic review and meta-analysis of longitudinal studie
Author: Liu, Xiao; Ling, Jitao; Wu, Yifan; Zhao, Huilei; Hu, Yuzhe; Yan, Zhiwei; Zhu, Wengen; Yu, Peng; Wang, Jinfeng; Zhang, Yuling; Bucci, Tommaso; Lip, Gregory Y. H

Journal: DIABETES & METABOLIC SYNDROME-CLINICAL RESEARCH & REVIEWS. 2025; Vol. 19, Issue 4, pp. -. DOI: 10.1016/j.dsx.2025.103228
6、Letter to the Editor regarding Global research trends and hotspots in gestational diabetes and long-term cardiovascular health: A bibliometric analysis
Author: Rao, Hao-Han; Guo, Feng; Tian, Jie

Journal: DIABETES & METABOLIC SYNDROME-CLINICAL RESEARCH & REVIEWS. 2025; Vol. 19, Issue 2, pp. -. DOI: 10.1016/j.dsx.2025.103190
7、The predictive value of estimated glucose disposal rate for all-cause and cardiovascular mortality in the US non-diabetic population aged ≥60 years: A population-based cohort stud
Author: Zhu, Botao; Cao, Chenghui; Liu, Wenwu; Liu, Yuxuan; Luo, Yonghong; Peng, Daoquan

Journal: DIABETES & METABOLIC SYNDROME-CLINICAL RESEARCH & REVIEWS. 2025; Vol. 19, Issue 1, pp. -. DOI: 10.1016/j.dsx.2024.103182
8、Decoding the disproportionate risk factor landscape of global type 2 diabetes burden in adults: An attribution analysis from 1990 to 205
Author: Huang, Yue; Wang, Jingxuan; Xu, Lan; Feng, Nannan; Du, Xihao; Chen, Meng; Li, Yiyuan; Yang, Guangrui; Wang, Hui; Zhong, Victor W.

Journal: DIABETES & METABOLIC SYNDROME-CLINICAL RESEARCH & REVIEWS. 2025; Vol. 19, Issue 1, pp. -. DOI: 10.1016/j.dsx.2024.103181